Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

84B1CA21579E3E93872587E40076EFCB Hearing Summary




PUBLIC
BILL SUMMARY For SB22-027

SENATE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Feb 9, 2022      
Location SCR 357



SB22-027 - Referred to the Committee of the Whole - Consent Calendar


02:43:01 PM  

Senator Smallwood and Senator Rodriguez, co-prime sponsor, presented Senate Bill 22-027, makes modifications to the Prescription Drug Monitoring Program(PDMP), including: requiring each prescriber holding a Colorado license and a current federal Drug Enforcement Administration (DEA) registration to register and maintain a PDMP user account; requiring a prescriber to query the PDMP prior to prescribing any opioid or benzodiazepine; clarifying that each pharmacist holding a Colorado license is required to maintain a user account with the PDMP; and requiring that the Prescription Drug Monitoring Task Force evaluate and make recommendations to the Executive Director of DORA regarding balancing enforcement of the PDMP with its use as a healthcare tool.

02:43:02 PM  
Mrs. Jenny Page, representing Office of the State Auditor, was available to answer committee questions.
02:53:46 PM  

Ms Ronne Hines, representing Department of Regulatory Agencies (DORA), testified in support of the bill.

Additional written testimony can be found in Attachment C.



02:59:12 PM
Motion Refer Senate Bill 22-027 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.
Moved Smallwood
Seconded
Buckner Yes
Jaquez Lewis Yes
Kirkmeyer Yes
Simpson Yes
Smallwood Yes
Ginal Yes
Fields Yes
Final YES: 7   NO: 0   EXC: 0   ABS:  0   FINAL ACTION:  PASS






The Colorado Senate and House of Representatives will not convene on Monday, January 20, 2025 in observance of Dr. Martin Luther King Jr. day.

The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details